Apr 1, 2026 08:16AM
Apr 1, 2026 08:14AM
Mar 24, 2026 08:16AM
Mar 24, 2026 08:13AM
Feb 24, 2026 04:18PM
Feb 24, 2026 04:15PM
Dec 3, 2025 02:00PM Hoth Therapeutics provides pipeline update on four drug programs
Dec 3, 2025 02:00PM
Oct 21, 2025 08:23AM
Oct 21, 2025 08:23AM
Sep 10, 2025 08:29AM
Sep 10, 2025 08:29AM
Sep 2, 2025 08:16AM
Sep 2, 2025 08:16AM Hoth Therapeutics' Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards
Jun 24, 2025 10:36AM
Jun 24, 2025 10:36AM
May 12, 2025 07:31AM
May 12, 2025 07:30AM
May 12, 2025 07:30AM
Apr 2, 2025 08:02AM
Apr 2, 2025 07:58AM Hoth Therapeutics Inc. (HOTH) Announces Positive Pre Clinical Data HT-ALZ Shows Promising Breakthrough in Alzheimer's Disease
Apr 2, 2025 07:58AM
Aug 15, 2024 08:04AM
Aug 15, 2024 08:04AM
Feb 26, 2024 08:12AM
Feb 26, 2024 08:11AM
Feb 5, 2024 06:31AM
Jan 18, 2024 08:20AM Hoth Therapeutics Inc. (HOTH) Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
Jan 18, 2024 08:20AM
Dec 27, 2023 08:21AM
Dec 27, 2023 08:21AM
Dec 5, 2023 08:33AM
Dec 5, 2023 08:33AM
Nov 14, 2023 08:37AM
Nov 14, 2023 08:37AM Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT
Oct 2, 2023 08:34AM
Oct 2, 2023 08:33AM
Sep 13, 2023 08:16AM
Sep 13, 2023 08:16AM
Sep 11, 2023 10:04AM
Sep 11, 2023 10:04AM
Jul 19, 2023 08:03AM Hoth Therapeutics Inc. (HOTH) Receives Protocol Approval for HT-001 Cancer Therapeutic
Jul 19, 2023 08:02AM
Jun 14, 2023 08:12AM
Jun 14, 2023 08:12AM
Apr 26, 2023 08:18AM
Apr 26, 2023 08:18AM
Feb 28, 2023 09:09AM
Dec 29, 2022 08:46AM Hoth Therapeutics (HOTH) Announces FDA Acceptance of IND Application for HT-001 for Treatment of Cancer Disorders Associated with EGFR Inhibitor Therapy
Dec 29, 2022 08:45AM

323,190 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All